Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.074 | 0.7 |
mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.022 | 0.7 |